The correlation of clinical evaluation with life quality and mental status in a Chinese cohort with dysferlinopathy

[1]  T. Feng,et al.  Anxiety and depression in adult-onset Still’s disease patients and associations with health-related quality of life , 2020, Clinical Rheumatology.

[2]  C. Zhai,et al.  Effect of exercise-based cardiac rehabilitation on clinical outcomes in patients with myocardial infarction in the absence of obstructive coronary artery disease (MINOCA): A prospective cohort study. , 2020, International journal of cardiology.

[3]  L. Padua,et al.  Psychosocial impact of sport activity in neuromuscular disorders , 2020, Neurological Sciences.

[4]  M. Jensen,et al.  Longitudinal associations between physical activity, anxiety, and depression in adults with long-term physical disabilities. , 2020, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[5]  J. Vles,et al.  Instruments for the Assessment of Behavioral and Psychosocial Functioning in Duchenne and Becker Muscular Dystrophy; a Systematic Review of the Literature. , 2019, Journal of pediatric psychology.

[6]  I. Nonaka,et al.  Psychiatric and neurodevelopmental aspects of Becker muscular dystrophy , 2019, Neuromuscular Disorders.

[7]  R. Kessels,et al.  Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis. , 2019, Journal of affective disorders.

[8]  Hanns Lochmüller,et al.  Disease burden of myotonic dystrophy type 1 , 2019, Journal of Neurology.

[9]  N. Watanabe,et al.  Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1 , 2019, Neuropsychiatric disease and treatment.

[10]  V. Zhang,et al.  The clinical spectrum and genetic variability of limb-girdle muscular dystrophy in a cohort of Chinese patients , 2018, Orphanet Journal of Rare Diseases.

[11]  J. Kao,et al.  The effect of interferon‐free regimens on health‐related quality of life in East Asian patients with chronic hepatitis C , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[12]  Yen-Mou Lu,et al.  Quality of life of patients with Duchenne muscular dystrophy: from adolescence to young men , 2017, Disability and rehabilitation.

[13]  B. Sañudo,et al.  Depression symptoms are associated with key health outcomes in women with fibromyalgia: a cross‐sectional study , 2017, International journal of rheumatic diseases.

[14]  L. Espinoza,et al.  Limb‐Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy , 2017, The American journal of the medical sciences.

[15]  P. Cuijpers,et al.  Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis , 2017, Journal of the Neurological Sciences.

[16]  V. Rakocevic-Stojanovic,et al.  Five‐year study of quality of life in myotonic dystrophy , 2016, Acta neurologica Scandinavica.

[17]  Wei Zhang,et al.  Dysferlin Gene Mutation Spectrum in a Large Cohort of Chinese Patients with Dysferlinopathy , 2016, Chinese medical journal.

[18]  A. Pestronk,et al.  The Clinical Outcome Study for dysferlinopathy , 2016, Neurology: Genetics.

[19]  H. Lv,et al.  Heterogeneous characteristics of MRI changes of thigh muscles in patients with dysferlinopathy , 2016, Muscle & nerve.

[20]  S. Youssof,et al.  The relationship between physical symptoms and health‐related quality of life in oculopharyngeal muscular dystrophy , 2016, Muscle & nerve.

[21]  Laura Manea,et al.  Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. , 2016, General hospital psychiatry.

[22]  E. Bertini,et al.  Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study , 2016, Neuromuscular Disorders.

[23]  Laura Manea,et al.  Screening and case finding for major depressive disorder using the Patient Health Questionnaire (PHQ-9): a meta-analysis. , 2015, General hospital psychiatry.

[24]  S. Fukuhara,et al.  Association between hand-grip strength and depressive symptoms: Locomotive Syndrome and Health Outcomes in Aizu Cohort Study (LOHAS). , 2015, Age and ageing.

[25]  Min Zhao,et al.  Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. , 2014, General hospital psychiatry.

[26]  S. Kyle,et al.  A systematic review of quality of life in adults with muscle disease , 2011, Journal of Neurology.

[27]  K. Bushby,et al.  One gene, one or many diseases? , 2010, Neurology.

[28]  L. Samuelsson,et al.  Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates , 2010, Behavioral and Brain Functions.

[29]  Jay J. Han,et al.  The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy , 2010, Muscle & nerve.

[30]  Wenbin Liu,et al.  Health related quality of life measured by SF-36: a population-based study in Shanghai, China , 2008, BMC public health.

[31]  A. Pestronk,et al.  Limb-Girdle Muscular Dystrophy in the United States , 2006, Journal of neuropathology and experimental neurology.

[32]  C. Béroud,et al.  Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies , 2005, Human mutation.

[33]  Y. Shen,et al.  Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation , 2003, Journal of epidemiology and community health.

[34]  J. Beckmann,et al.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.

[35]  Pieter J. de Jong,et al.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy , 1998, Nature Genetics.

[36]  M. Duveneck,et al.  Depression in myotonic muscular dystrophy. , 1986, Archives of physical medicine and rehabilitation.